Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.
Phase II study of neoadjuvant FLOT and chemoradiation for trimodality therapy of esophageal/GEJ adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results